We investigated the role of circulating adipokines in long-term breast cancer prognosis using measurements from two time-points around 5 years apart in a large cohort of postmenopausal breast cancer patients and examined potential associations of time-varying leptin, adiponectin and resistin with all-cause mortality, BCM and risk of recurrence. This evidence concerns the gene ADIPOQ and breast cancer.